| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |